Meeder Advisory Services, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1792167 DUBLIN, OH

Position in REGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$817,460

-$241,829 QoQ

Shares Held

1,311

-4.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#684

of 1,320 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Meeder Advisory Services, Inc. holds $10,646,226 across 17 Biotechnology names. REGN ranks #3 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,415	$3,186,522
2	RPRX	Royalty Pharma plc	19,242	$1,078,898
3	REGN	Regeneron Pharmaceuticals, Inc. This page	1,311	$817,460
4	RVMD	Revolution Medicines, Inc.	3,922	$734,512
5	IONS	Ionis Pharmaceuticals Inc	7,660	$607,361
6	MRNA	Moderna, Inc.	7,734	$541,612
7	ALNY	Alnylam Pharmaceuticals, Inc.	1,611	$484,959
8	PCVX	Vaxcyte, Inc.	7,785	$452,542

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$817,460	1,311	-4.4%	Shares	Sole	2026-08-07
2026-03-31	$1,059,289	1,371	+9.7%	Shares	Sole	2026-05-07
2025-12-31	$964,837	1,250	+1.7%	Shares	Sole	2026-02-11
2025-09-30	$691,029	1,229	+3.5%	Shares	Sole	2025-10-24
2025-06-30	$623,175	1,187	-20.8%	Shares	Sole	2025-08-07
2025-03-31	$950,076	1,498	-12.3%	Shares	Sole	2025-05-07
2024-12-31	$1,216,659	1,708	-12.6%	Shares	Sole	2025-02-12
2024-09-30	$2,055,174	1,955	+4.6%	Shares	Sole	2024-11-07
2024-06-30	$1,964,375	1,869	+41.9%	Shares	Sole	2024-08-08
2024-03-31	$1,267,599	1,317	+4.1%	Shares	Sole	2024-05-07
2023-12-31	$1,111,036	1,265	+3.4%	Shares	Sole	2024-01-25
2023-09-30	$1,006,480	1,223	-18.4%	Shares	Sole	2023-11-13
2023-06-30	$1,077,091	1,499	+1.1%	Shares	Sole	2023-08-11
2023-03-31	$1,217,714	1,482	+13.6%	Shares	Sole	2023-05-15
2022-12-31	$941,544	1,305	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.